114 related articles for article (PubMed ID: 16633084)
1. Possible involvement of calpain activation in pathogenesis of chronic heart failure after acute myocardial infarction.
Takahashi M; Tanonaka K; Yoshida H; Koshimizu M; Daicho T; Oikawa R; Takeo S
J Cardiovasc Pharmacol; 2006 Mar; 47(3):413-21. PubMed ID: 16633084
[TBL] [Abstract][Full Text] [Related]
2. Effects of ACE inhibitor and AT1 blocker on dystrophin-related proteins and calpain in failing heart.
Takahashi M; Tanonaka K; Yoshida H; Oikawa R; Koshimizu M; Daicho T; Toyo-Oka T; Takeo S
Cardiovasc Res; 2005 Feb; 65(2):356-65. PubMed ID: 15639474
[TBL] [Abstract][Full Text] [Related]
3. Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction.
Yoshida H; Takahashi M; Koshimizu M; Tanonaka K; Oikawa R; Toyo-oka T; Takeo S
Cardiovasc Res; 2003 Aug; 59(2):419-27. PubMed ID: 12909325
[TBL] [Abstract][Full Text] [Related]
4. Effects of angiotensin I-converting enzyme inhibitor and angiotensin II type 1 receptor blocker on the right ventricular sarcoglycans and dystrophin after left coronary artery ligation.
Takahashi M; Tanonaka K; Yoshida H; Koshimizu M; Oikawa R; Daicho T; Takeo S
Eur J Pharmacol; 2005 Oct; 522(1-3):84-93. PubMed ID: 16185685
[TBL] [Abstract][Full Text] [Related]
5. Changes in Hsp60 level of the failing heart following acute myocardial infarction and the effect of long-term treatment with trandolapril.
Toga W; Tanonaka K; Takeo S
Biol Pharm Bull; 2007 Jan; 30(1):105-10. PubMed ID: 17202668
[TBL] [Abstract][Full Text] [Related]
6. Beneficial effects of sampatrilat, a novel vasopeptidase inhibitor, on cardiac remodeling and function of rats with chronic heart failure following left coronary artery ligation.
Maki T; Nasa Y; Tanonaka K; Takahashi M; Takeo S
J Pharmacol Exp Ther; 2003 Apr; 305(1):97-105. PubMed ID: 12649357
[TBL] [Abstract][Full Text] [Related]
7. Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961.
Sandmann S; Prenzel F; Shaw L; Schauer R; Unger T
Br J Pharmacol; 2002 Apr; 135(8):1951-8. PubMed ID: 11959798
[TBL] [Abstract][Full Text] [Related]
8. Myocardial heat shock proteins during the development of heart failure.
Tanonaka K; Yoshida H; Toga W; Furuhama K; Takeo S
Biochem Biophys Res Commun; 2001 May; 283(2):520-5. PubMed ID: 11327732
[TBL] [Abstract][Full Text] [Related]
9. Effect of long-term treatment with trandolapril on Hsp72 and Hsp73 induction of the failing heart following myocardial infarction.
Tanonaka K; Toga W; Yoshida H; Furuhama K; Takeo S
Br J Pharmacol; 2001 Nov; 134(5):969-76. PubMed ID: 11682444
[TBL] [Abstract][Full Text] [Related]
10. Induction of heat shock protein 72 in the failing heart is attenuated after an exposure to heat shock.
Tanonaka K; Toga W; Takahashi M; Yoshida H; Oikawa R; Takeo S
Mol Cell Biochem; 2004 Apr; 259(1-2):211-5. PubMed ID: 15124926
[TBL] [Abstract][Full Text] [Related]
11. Expression and immunolocalization of the calpain-calpastatin system during parthenogenetic activation and fertilization in the rat egg.
Haim K; Ben-Aharon I; Shalgi R
Reproduction; 2006 Jan; 131(1):35-43. PubMed ID: 16388007
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of mu-calpain, m-calpain, and calpastatin from postmortem muscle. I. Initial steps.
Camou JP; Mares SW; Marchello JA; Vazquez R; Taylor M; Thompson VF; Goll DE
J Anim Sci; 2007 Dec; 85(12):3400-14. PubMed ID: 17878283
[TBL] [Abstract][Full Text] [Related]
13. Myocardial heat shock protein changes in the failing heart following coronary artery ligation.
Tanonaka K; Toga W; Yoshida H; Takeo S
Heart Lung Circ; 2003; 12(1):60-5. PubMed ID: 16352108
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
15. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
Huang BS; White RA; Ahmad M; Tan J; Jeng AY; Leenen FH
Cardiovasc Res; 2009 Feb; 81(3):574-81. PubMed ID: 18689429
[TBL] [Abstract][Full Text] [Related]
16. Effects of KR-31378, a novel ATP-sensitive potassium channel activator, on hypertrophy of H9c2 cells and on cardiac dysfunction in rats with congestive heart failure.
Hwang GS; Oh KS; Koo HN; Seo HW; You KH; Lee BH
Eur J Pharmacol; 2006 Jul; 540(1-3):131-8. PubMed ID: 16729997
[TBL] [Abstract][Full Text] [Related]
17. Potential novel pharmacological therapies for myocardial remodelling.
Landmesser U; Wollert KC; Drexler H
Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
[TBL] [Abstract][Full Text] [Related]
18. Decreased sensitivity of lens-specific calpain Lp82 to calpastatin inhibitor.
Nakamura Y; Fukiage C; Ma H; Shih M; Azuma M; Shearer TR
Exp Eye Res; 1999 Aug; 69(2):155-62. PubMed ID: 10433852
[TBL] [Abstract][Full Text] [Related]
19. High-dose 17beta-estradiol treatment prevents development of heart failure post-myocardial infarction in the rat.
Beer S; Reincke M; Kral M; Callies F; Strömer H; Dienesch C; Steinhauer S; Ertl G; Allolio B; Neubauer S
Basic Res Cardiol; 2007 Jan; 102(1):9-18. PubMed ID: 16817027
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II type 1 receptor blocker attenuates exacerbated left ventricular remodeling and failure in diabetes-associated myocardial infarction.
Matsusaka H; Kinugawa S; Ide T; Matsushima S; Shiomi T; Kubota T; Sunagawa K; Tsutsui H
J Cardiovasc Pharmacol; 2006 Sep; 48(3):95-102. PubMed ID: 17031262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
